ProCE Banner Activity

Selective RET Inhibition in Metastatic RET-Mutant Medullary Thyroid Cancer and RET Fusion–Positive Differentiated Thyroid Cancer

Slideset Download
Download these slides from a CCO Live Webinar to review the latest clinical data informing optimal treatment of metastatic RET-altered thyroid cancer.

Released: March 16, 2021

Expiration: March 15, 2022

No longer available for credit.

Share

Faculty

Marcia Brose

Marcia Brose, MD, PhD, FASCO

Professor
Department of Medical Oncology
Sidney Kimmel Medical College
Thomas Jefferson University
Director, Sidney Kimmel Cancer Center
Vice Chair, Medical Oncology
Sidney Kimmel Medical College
Jefferson Northeast
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Marcia Brose, MD, PhD, FASCO

Professor
Department of Medical Oncology
Sidney Kimmel Medical College
Thomas Jefferson University
Director, Sidney Kimmel Cancer Center
Vice Chair, Medical Oncology
Sidney Kimmel Medical College
Jefferson Northeast
Philadelphia, Pennsylvania